Abstract: The present invention relates to a method for regulating wrinkles and/or atrophy in mammalian skin comprising treating the skin with a safe and effective amount of salicylic acid and/or additional active component.
Abstract: The invention involves pharmaceutical compositions for topical application comprising:(a) a safe and effective amount of a pharmaceutical active; and(b) from about 0.05% to about 5% of a non-ionic polyacrylamide having a molecular wight of from about 1,000,000 to about 30,000,000.
Type:
Grant
Filed:
March 27, 1998
Date of Patent:
February 23, 1999
Assignee:
Richardson-Vicks Inc.
Inventors:
George Endel Deckner, Brian Scott Lombardo
Abstract: The present invention relates to a method for regulating wrinkles and/or atrophy in mammalian skin comprising treating the skin with a safe and effective amount of salicylic acid and/or additional active component.
Abstract: The present invention relates to a method for regulating wrinkles and/or atrophy in mammalian skin comprising treating the skin with a safe and effective amount of salicylic acid and/or additional active component.
Abstract: The present invention relates to a method for regulating wrinkles and/or atrophy in mammalian skin comprising treating the skin with a safe and effective amount of salicylic acid and/or additional active component.
Abstract: The present invention relates to a method for regulating wrinkles and/or atrophy in mammalian skin comprising treating the skin with a safe and effective amount of salicylic acid and/or additional active component.
Abstract: The present invention relates to a method for regulating wrinkles and/or atrophy in mammalian skin comprising treating the skin with a safe and effective amount of salicylic acid and/or additional active component.
Abstract: The present invention relates to a method for regulating wrinkles and/or atrophy in mammalian skin comprising treating the skin with a safe and effective amount of salicylic acid and/or additional active component.
Abstract: The present invention relates to a method for regulating wrinkles and/or atrophy in mammalian skin comprising treating the skin with a safe and effective amount of salicylic acid and/or additional active component.
Abstract: The present invention relates to a method for regulating wrinkles and/or atrophy in mammalian skin comprising treating the skin with a safe and effective amount of salicylic acid and/or additional active component.
Abstract: The invention involves pharmaceutical compositions for topical application comprising:(a) a safe and effective amount of a pharmaceutical active; and(b) from about 0.05% to about 5% of a non-ionic polyacrylamide having a molecular wight of from about 1,000,000 to about 30,000,000.
Type:
Grant
Filed:
June 5, 1995
Date of Patent:
July 14, 1998
Assignee:
Richardson-Vicks Inc.
Inventors:
George Endel Deckner, Brian Scott Lombardo
Abstract: The present invention relates to a method for regulating wrinkles and/or atrophy in mammalian skin comprising treating the skin with a safe and effective amount of salicylic acid and/or additional active component.
Abstract: The invention involves pharmaceutical compositions for topical application comprising:(a) a safe and effective amount of a pharmaceutical active; and(b) from about 0.05% to about 5% of a non-ionic polyacrylamide having a molecular weight of from about 1,000,000 to about 30,000,000.
Type:
Grant
Filed:
June 6, 1995
Date of Patent:
July 7, 1998
Assignee:
Richardson-Vicks Inc.
Inventors:
George Endel Deckner, Brian Scott Lombardo
Abstract: The invention involves pharmaceutical compositions for topical application comprising:(a) a safe and effective amount of a pharmaceutical active; and(b) from about 0.05% to about 5% of a non-ionic polyacrylamide having a molecular wight of from about 1,000,000 to about 30,000,000.
Type:
Grant
Filed:
June 5, 1995
Date of Patent:
June 30, 1998
Assignee:
Richardson-Vicks Inc.
Inventors:
George Endel Deckner, Brian Scott Lombardo
Abstract: The present invention relates to a method for regulating wrinkles and/or atrophy in mammalian skin comprising treating the skin with a safe and effective amount of salicylic acid and/or additional active component.
Abstract: The invention involves pharmaceutical compositions for topical application comprising:(a) a safe and effective amount of a pharmaceutical active; and(b) from about 0.05% to about 5% of a non-ionic polyacrylamide having a molecular weight of from about 1,000,000 to about 30,000,000.
Type:
Grant
Filed:
June 5, 1995
Date of Patent:
May 26, 1998
Assignee:
Richardson-Vicks Inc.
Inventors:
George Endel Deckner, Brian Scott Lombardo
Abstract: The invention involves pharmaceutical compositions for topical application comprising:(a) a safe and effective amount of a pharmaceutical active; and(b) from about 0.05% to about 5% of a non-ionic polyacrylamide having a molecular weight of from about 1,000,000 to about 30,000,000.
Type:
Grant
Filed:
June 5, 1995
Date of Patent:
May 26, 1998
Assignee:
Richardson-Vicks Inc.
Inventors:
George Endel Deckner, Brian Scott Lombardo
Abstract: A skin care composition in the form of a low pH aqueous gel. The compositions provide improved skinfeel and residue characteristics together with excellent moisturizing, emolliency, rub-in and absorption characteristics.
Type:
Grant
Filed:
May 25, 1994
Date of Patent:
January 13, 1998
Assignee:
Richardson-Vicks Inc.
Inventors:
George Endel Deckner, Brian Scott Lombardo
Abstract: The present invention relates to a method for regulating wrinkles and/or atrophy in mammalian skin comprising treating the skin with a safe and effective amount of salicylic acid and/or additional active component.
Abstract: The present invention relates to a method for regulating wrinkles and/or atrophy to mammalian skin comprising treating the skin with a safe and effective amount of salicylic add and/or additional active component.